| Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in … D Eratne, SM Loi, QX Li, C Stehmann, CB Malpas, A Santillo, S Janelidze, ... Alzheimer's & Dementia 18 (11), 2218-2233, 2022 | 38 | 2022 |
| Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders D Eratne, M Kang, C Malpas, S Simpson-Yap, C Lewis, C Dang, J Grewal, ... Australian & New Zealand Journal of Psychiatry 58 (1), 70-81, 2024 | 21 | 2024 |
| Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors D Eratne, M Keem, C Lewis, M Kang, M Walterfang, S Farrand, S Loi, ... Journal of the Neurological Sciences 442, 120439, 2022 | 16 | 2022 |
| Carer burden and psychological distress in young‐onset dementia: An Australian perspective M Kang, S Farrand, M Walterfang, D Velakoulis, SM Loi, A Evans International journal of geriatric psychiatry 37 (7), 2022 | 15 | 2022 |
| Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetes MJL Hare, JM Deitch, MJY Kang, LA Bach Internal medicine journal 51 (8), 1292-1297, 2021 | 10 | 2021 |
| Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders MJY Kang, D Eratne, H Dobson, CB Malpas, M Keem, C Lewis, J Grewal, ... Acta Neuropsychiatrica 36 (1), 17-28, 2024 | 9 | 2024 |
| Collective pause: improving staff performance in acute medicine through a brief mindfulness‐based group programme M Kang, H Gibbs, R Selzer, AR Hudaib, AK Aung, J Gibbs Internal Medicine Journal 52 (8), 1394-1401, 2022 | 4 | 2022 |
| A case of an incidental primary adrenal lymphoma in a patient with newly diagnosed human immunodeficiency virus. MM Britto, MJY Kang, S Goare, A Pham, JT Hong, J Serpell, S Grodski ANZ Journal of Surgery 89 (3), 2019 | 4 | 2019 |
| Comparing survival and mortality in patients with late-onset and young-onset vascular dementia MJ Yoo, M Kang, P Tsoukra, Z Chen, S Farrand, W Kelso, A Evans, ... International Psychogeriatrics 35 (9), 519-527, 2023 | 3 | 2023 |
| Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis MJY Kang, J Grewal, D Eratne, C Malpas, WH Chiu, K Katisko, E Solje, ... Brain, Behavior, and Immunity, 2024 | 2 | 2024 |
| Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting D Eratne, MJY Kang, C Lewis, C Dang, CB Malpas, M Keem, J Grewal, ... Alzheimer's & Dementia 20 (11), 7989-8001, 2024 | 2 | 2024 |
| Diagnostic utility of plasma ptau217, ptau181, GFAP for Alzheimer disease in a heterogeneous younger onset dementia clinical cohort D Eratne, QX Li, C Lewis, C Dang, M Kang, J Grewal, S Loi, M Walterfang, ... medRxiv, 2024.04. 29.24306586, 2024 | 2 | 2024 |
| Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders D Eratne, MJY Kang, C Lewis, C Dang, C Malpas, S Ooi, A Brodtmann, ... Journal of the Neurological Sciences 467, 123291, 2024 | 1 | 2024 |
| Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders H Dobson, S Al Maawali, C Malpas, AF Santillo, M Kang, M Todaro, ... Epilepsia 65 (9), 2751-2763, 2024 | 1 | 2024 |
| Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis MJY Kang, D Eratne, C Wannan, AF Santillo, D Velakoulis, C Pantelis, ... Schizophrenia Research 267, 269-272, 2024 | 1 | 2024 |
| Improving healthcare team harmony through collaborative team reflection and mindfulness MJY Kang, AK Aung, J Gibbs, H Gibbs medRxiv, 2023.07. 25.23293060, 2023 | 1 | 2023 |
| Huntington's disease: Mortality and risk factors in an Australian cohort E Sun, M Kang, P Wibawa, V Tsoukra, Z Chen, S Farrand, D Eratne, ... Journal of the Neurological Sciences 442, 120437, 2022 | 1 | 2022 |
| Cerebrospinal fluid neurofilament light improves accurate distinction between neurodegenerative and psychiatric disorders at a cognitive neuropsychiatry service M Kang, D Eratne, H Dobson, CB Malpas, M Keem, C Lewis, J Grewal, ... medRxiv, 2022.09. 08.22279663, 2022 | 1 | 2022 |
| Plasma neurofilament light chain and phosphorylated tau 181 in neurodegenerative and psychiatric disorders: moving closer towards a simple diagnostic test like a'C‐reactive … D Eratne, A Santillo, QX Li, M Kang, M Keem, C Lewis, SM Loi, ... Alzheimer's & Dementia 17, e058647, 2021 | 1 | 2021 |
| Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort D Eratne, QX Li, C Lewis, C Dang, MJY Kang, J Grewal, S Loi, ... Journal of Neurology 272 (1), 1-12, 2025 | | 2025 |
